Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial. - Raygan, F; Ostadmohammadi, V; Bahmani, F (Clin Nutr, 2019)